Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on FormS-8 of our report dated September 18, 2018 (which report expresses an unqualified opinion and includes an explanatory paragraph relating to the substantial doubt about the Company’s ability to continue as a going concern), appearing in the Annual Report on Form10-K of EyePoint Pharmaceuticals, Inc. for the year ended June 30, 2018.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
September 25, 2018